The association between high levels of TYMS in tumours and poor clinical response following 5-FU treatment of colorectal cancer is well documented (Johnston et al, 1995; Leichman et al, 1997; Salonga et al, 2000; Iacopetta et al, 2001). Here, TYMS is linked to neoplasm.